NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 292 filers reported holding NOVOCURE LTD in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $355,655 | -28.8% | 8,570 | +3.2% | 0.00% | -40.0% |
| Q1 2023 | $499,342 | -18.0% | 8,303 | 0.0% | 0.01% | -28.6% |
| Q4 2022 | $609,025 | -13.0% | 8,303 | -9.8% | 0.01% | -12.5% |
| Q3 2022 | $700,000 | -6.8% | 9,210 | -14.7% | 0.01% | +14.3% |
| Q2 2022 | $751,000 | -37.2% | 10,802 | -25.1% | 0.01% | -12.5% |
| Q1 2022 | $1,195,000 | -2.6% | 14,425 | -11.7% | 0.01% | +14.3% |
| Q4 2021 | $1,227,000 | -38.7% | 16,336 | -5.2% | 0.01% | -41.7% |
| Q3 2021 | $2,002,000 | -47.0% | 17,231 | +1.2% | 0.01% | -47.8% |
| Q2 2021 | $3,777,000 | +101.8% | 17,027 | +20.2% | 0.02% | +76.9% |
| Q1 2021 | $1,872,000 | -25.5% | 14,162 | -2.4% | 0.01% | -27.8% |
| Q4 2020 | $2,512,000 | – | 14,515 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $77,833,000 | 15.51% |
| HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
| Darsana Capital Partners LP | 700,000 | $155,274,000 | 4.42% |
| MORGAN JESS S & CO INC | 23,775 | $5,274,000 | 3.47% |
| Soleus Capital Management, L.P. | 98,975 | $21,955,000 | 3.38% |
| Montanaro Asset Management Ltd | 116,650 | $25,875,000 | 3.26% |
| Taylor Frigon Capital Management LLC | 31,035 | $6,884,000 | 2.15% |
| Rhenman & Partners Asset Management AB | 120,000 | $26,618,000 | 1.81% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $2,218,000 | 1.33% |
| Derbend Asset Management | 5,789 | $1,284,000 | 1.20% |